| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0029524.6AGB0029524D0 (en) | 2000-12-04 | 2000-12-04 | Disease treatment |
| PCT/GB2001/005369WO2002045704A2 (en) | 2000-12-04 | 2001-12-04 | Prevention and treatment of tachyphylactic response |
| AU2002222125AAU2002222125A1 (en) | 2000-12-04 | 2001-12-04 | Prevention and treatment of tachyphylactic response |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0029524.6AGB0029524D0 (en) | 2000-12-04 | 2000-12-04 | Disease treatment |
| Publication Number | Publication Date |
|---|---|
| GB0029524D0true GB0029524D0 (en) | 2001-01-17 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0029524.6ACeasedGB0029524D0 (en) | 2000-12-04 | 2000-12-04 | Disease treatment |
| Country | Link |
|---|---|
| AU (1) | AU2002222125A1 (en) |
| GB (1) | GB0029524D0 (en) |
| WO (1) | WO2002045704A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0128415D0 (en)* | 2001-11-27 | 2002-01-16 | Univ Sheffield | Medicaments |
| GB0128628D0 (en)* | 2001-11-29 | 2002-01-23 | Univ Sheffield | Disease treatment |
| US7334968B2 (en)* | 2002-02-22 | 2008-02-26 | Jennmar Corporation | Yieldable prop |
| WO2006032299A1 (en)* | 2004-09-24 | 2006-03-30 | Susanna Miettinen | Use of inhibitors of 24-hydroxylase in the treatment of cancer |
| EP2173875B1 (en)* | 2007-06-15 | 2017-08-30 | Cequent Pharmaceuticals, Inc. | Bacteria mediated gene silencing |
| WO2024223797A1 (en) | 2023-04-28 | 2024-10-31 | Institut National de la Santé et de la Recherche Médicale | Use of cyp3a4 inhibitors for the treatment of hepatitis d virus (hdv) infections |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9409882D0 (en)* | 1994-05-18 | 1994-07-06 | Sandoz Ltd | Organic compounds |
| US5658881A (en)* | 1994-10-14 | 1997-08-19 | Twk, Inc. | Method for topical inhibition of the metabolic activity of cytochrome P450 |
| US5998393A (en)* | 1996-04-05 | 1999-12-07 | Kang; Sewon | Methods for assessing 1,25(OH)2 D3 activity in skin and for enhancing the therapeutic use of 1,25(OH)2 D3 |
| GB9800040D0 (en)* | 1998-01-02 | 1998-03-04 | Univ Cardiff | Pyrrolidine dione derivatives |
| US20010041706A1 (en)* | 2000-03-24 | 2001-11-15 | Synold Timothy W. | Blockade of taxane metabolism |
| Publication number | Publication date |
|---|---|
| AU2002222125A1 (en) | 2002-06-18 |
| WO2002045704A2 (en) | 2002-06-13 |
| WO2002045704A3 (en) | 2003-05-01 |
| Publication | Publication Date | Title |
|---|---|---|
| GB0028264D0 (en) | Well treatment | |
| GB0028269D0 (en) | Well treatment | |
| EG22308A (en) | Tobacco treatment | |
| AU6282901A (en) | Medical arrangement | |
| GB0009606D0 (en) | Therapeutic combinations | |
| GB0009591D0 (en) | Medical combinations | |
| GB0011244D0 (en) | Tissue regrafting | |
| PL362855A1 (en) | Improved treatment | |
| EG25829A (en) | Novel treatment | |
| GB0030845D0 (en) | Novel treatment | |
| GB0001710D0 (en) | Therapeutic treatment | |
| GB0029524D0 (en) | Disease treatment | |
| AU2096002A (en) | Therapeutic treatment | |
| GB0030541D0 (en) | Medical uses | |
| GB0026015D0 (en) | Cancer treatment | |
| GB0128628D0 (en) | Disease treatment | |
| GB0031321D0 (en) | Treatment | |
| GB0029125D0 (en) | Novel treatment | |
| GB2358857B (en) | Coffins | |
| GB0019728D0 (en) | Novel treatment | |
| GB0012793D0 (en) | Treatment | |
| GB0017495D0 (en) | Treatment | |
| GB0020669D0 (en) | Alopica treatment | |
| GB0012760D0 (en) | Treatment | |
| GB0006415D0 (en) | Treatment |
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) | ||
| COOA | Change in applicant's name or ownership of the application |